XON7 for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Nov 2023: Trial started, NCT06154291
  2. 4 Dec 2023: Trial registered, NCT06154291

The trials

NCT06154291: FIH XON7 in Advanced/Metastatic Solid Tumors

State
Under way
Phase
Phase 1 and Phase 2
People
255 planned
Started
14 Nov 2023
Primary completion
Dec 2026
Arms
Dose Escalation part then Expansion part
Results
None posted
  1. 14 Nov 2023: Trial started
  2. 4 Dec 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.